Impact factor: 9.111
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured.
Impact Factor: 9.111 (Number 1 original research journal in the field of Rheumatology)
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ARD.
View free sample issue >>
Just published and free to read: Updated EULAR recommendations on managing RA with synthetic and biological DMARDs.
Textbooks from EULAR
Just published: The EULAR Textbook on Systemic Sclerosis is the most up to date textbook on scleroderma, written by experts from EULAR/EUSTAR.
Also available: The latest edition of the EULAR Textbook on Rheumatic Diseases, the most comprehensive textbook for rheumatologists.
ARD publishes summaries for patients and non-clinicians that clearly explain the findings and treatment implications arising from key research papers published in the journal. Written by BMJ's Best Health team, they are also checked for accuracy by the ARD editors.
The 2013 ACR/EULAR classification criteria for systemic sclerosis is now available and free to read until the end of November.